Sun Pharma launches a generic Brevipil tablet.
Sun Pharma launches generic Brevipil tablet following patent expiry of the innovator product. (1) Sun Pharmaceuticals have recently launched an anti–epileptic drug called Brevipil in the market. The company did this launch on 22 February 2021, a day after the expiry of the innovator drug’s patent. The innovator drug for this generic version is called Brivaracetam. […]









